Overview and Registration Fees

There are ongoing significant advances in transfusion medicine and science with high quality research supporting evidence-based practice. This two day meeting organised on behalf of the Royal College of Pathologists brings together experts from various clinical disciplines with leaders in transfusion science to provide a broad overview of current key developments. The meeting will be of interest to all those involved in transfusion medicine.

We are also inviting submission of abstracts by medical trainees, laboratory scientists and transfusion practitioners. The best abstracts accepted for either oral or poster presentation at the symposium.  Please see further details under above 'Abstracts' tab.

Registration Fees

Two-day registration fees apply only. 

Registration is for both days but you can share this with a colleague so each attends one day.  One delegates should make the online payment and then email us to inform the name and contact email of the second attendee and which day they are attending

Two day fees 
RCPath Fellows £370
Concessions £190 (Trainees, BMS, Nurses, Retired)
Non-members £425

 

Transfusion conference attendee, November 2016

Good mixture of scientific and clinical topics.  Very welcome to see various methods of research and use of data.

I thought the discussion around current trials and EBM in relation to studies conducted was excellent.

'Real practice' examples very helpful. 

 

Programme

Thursday 22nd November 2018

10:00     Registration and coffee

10:30     Welcome - Professor Jo Martin, President, Royal College of Pathologists

 Foundation Lecture: Chair - Professor David Roberts, NHSBT

10:40     Keynote speaker - Professor Meghan Delaney, The George Washington University, Washington, USA

Evidence based transfusion practice: Chair – Dr Shubha Allard, Barts Health NHS Trust & NHSBT

11:20     International NAIT guideline - Professor Lani Lieberman, University of Toronto, Canada

11:45     Near patient haemostasis testing - challenges to implementation - Dr Jecko Thachil, Manchester University NHS Foundation Trust

12:10     Advances in Sickle cell Disease - Dr Jo Howard, Guy’s & St Thomas’ NHS Foundation Trust, London

12:35     Discussion

12.50     Percy Oliver Award for Achievements in Transfusion Medicine/Science

13.00     Lunch

Advances in transfusion science: Chair - Professor Mike Murphy, John Radcliffe Hospital & NHSBT

14:00     TTP and advances - Professor Marie Scully, University College London

14:25     Platelets - trials and guidelines -Dr Lise Estcourt, University of Oxford and NHSBT  

14:50     Organ transplantation – achievements & challenges - John Forsythe, Medical Director Organ Donation & Transplant, NHSBT

15:15     COFFEE

15:45     Tranexamic acid for all - Professor Beverley Hunt, Guy’s & St Thomas’ NHS Foundation Trust, London

16:10     Young investigator – 2 talks of 10 minutes each based on best abstract selection

16.30     Close

 

Viewing of posters elected as best abstracts will take place over lunch & coffee

 

 

Friday 23rd November 2018

 

09:00     Coffee

Transfusion safety: Chair - Professor Lorna Williamson, Royal College of Pathologists

09:30     21 years old - SHOT comes of age - Dr Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion

09:55     Blood Safety – learning from the past and looking to the future - Dr Ines Ushiro-Lumb, NHSBT and PHE

10:20     Horizon seeking - new components - Dr Rebecca Cardigan, Head of Components Development, NHSBT

10:45     Discussion

10:55     Coffee

 Clinical practice: Chair - Dr Megan Rowley, Scottish National Blood Transfusion Service

11:25     Aplastic Anaemia - Professor Judith Marsh, Kings College Hospital, London

11.50     INTERVAL Trial - genetic testing - Dr Adam Butterworth, University of Cambridge

12:15     Haemato oncology & transfusion - practical challenges - Dr Jonathan Wallis, Newcastle upon Tyne Hospitals NHS Foundation Trust

12:50     Discussion

13:00     LUNCH

Improving the impact of PBM: Chair - Dr Janet Birchall, Welsh Blood Service

14:00     Pre-op anaemia – how do we change practice? - Dr Alwyn Kotze, Leeds Teaching Hospitals NHS Trust

14:25     Patient Blood Management and Paediatrics - Professor Meghan Delaney

14:50     International Patient Blood Management Consensus conference - a summary- Dr Cynthia So-Osman, Sanquin, Netherlands

15:30     Close

Abstracts

Abstract Guidelines

Presentations

Two authors will be selected to give an oral presentation about their work. Each author will receive free meeting registration for the 22nd and 23rd November, free travel, and free overnight accommodation.

Posters

Ten authors will be selected to present a poster on the 22nd November. All poster authors will receive free meeting registration for the 22nd November. The best poster will receive a Wiley book prize.

 

All abstracts presented at the conference will be published in Transfusion Medicine.

IMPORTANT DATES

  • Abstract submission opens: 30th March 2018
  • Abstract submission closes: 14th September 2018
  • Abstract notification: Week commencing 22nd October 2018

Abstracts received after the deadline will not be accepted.

 

DEFINITIONS

Submitting author: person who physically submits the abstract

Presenting author: person who will physically present the abstract at the conference and who is marked as the presenter in the program.

First author: First author cited who scientifically endorses the abstract and is therefore responsible for its content

 

  1. Abstracts must be related to transfusion medicine.
  2. Abstracts can present results from audit, quality improvement, research, original small studies, educational interventions, or systematic reviews
  3. Abstracts submitted should be previously unpublished data
  4. The presenting author must be a doctor-in-training, transfusion practitioner, or laboratory scientist.
  5. Abbreviations should be defined.
  6. The abstract must contain a maximum of 300 words.
  7. The abstract must contain results, otherwise the abstracts will be unhelpful to future readers.
  8. When you submit an abstract for the first time you will be given a unique Reference Number. Please make a note of this so that, if required, you can recall and update/amend your submission. Abstracts can be amended up to midnight on 14th September 2018.
  9. Please ensure that your abstract does not contain spelling, grammatical or scientific errors. No corrections are possible after the submission deadline. The abstract will be reproduced exactly as submitted in the event materials. No proofreading will be done of the scientific content.
  10. If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to meetings@rcpath.org, no later than 30th September 2018.

AFTER THE SUBMISSION

  1. The Programme Committee reserve the right of final decisions regarding acceptance of abstracts and the form of presentation.
  2. The submitting authors will be notified in the week beginning the 22nd October 2018, at the email address provided during submission, whether their abstract has been accepted. It is the author’s responsibility to ensure that emails can reach them. They will be informed at the same time about the date, time and format of their presentation.

PRESENTATION OF ABSTRACTS

  1. Abstracts can be accepted either as a poster or oral presentation. Oral presentations will be advised of presentation time and length of presentation once abstract has been accepted.
  2. If your abstract is accepted as a poster, you will be requested to be available for discussion during the poster viewing session on 22nd November 2018. Please use letters large enough to be read from a distance of 1.5 meters (4.9 feet).
  3. Full presentation guidelines will be included in the acceptance letter and posted on the conference website.

ABSTRACT TYPING INSTRUCTIONS

  1. Maximum word count is 300 words (excluding title, author list and affiliations).
  2. Formatting your abstract Please use International characters only.
  3. Please type in "Normal sentence case", not all in CAPITALS.
  4. Make the title intelligible to all. Abbreviations should not be used in the title.
  5. List all authors and affiliations. Highlight presenting author with an *.
  6. Reduce abbreviations to a minimum, especially non-standard ones, and define at first use.
  7. Use only normal keyboard characters.
  8. All abstracts will be reproduced exactly as submitted so please check the text for typing errors before you submit.
  9. Please state within the submission e-mail whether the presenting author is a doctor-in-training, transfusion practitioner, or laboratory scientist.
  10. Please submit the abstract to meetings@rcpath.org

DISCLOSURES

Authors are responsible for reporting any real or perceived financial conflict of interest. A brief disclosure and conflict of interest statement should be included in the submitted abstract and viewable on the poster. Any potential for financial gain that may be derived from reported work may constitute a possible conflict of interest. Disclosure is required in any case in which an individual or company stands to benefit financially from research performed. Therefore, each author must indicate any benefit to an individual or company that may potentially lead to financial reward.

Disclosures should appear on the bottom left corner of the poster and may follow the recommended format: "Disclosures: None" or "Disclosures: The author/s (insert preferred abbreviation) disclose a relationship with..."

 

Speakers

Speakers CB19

  • Dr Mark Gurnell

    Mark Gurnell is Professor of Clinical Endocrinology and Clinical SubDean at the University of Cambridge. Together with his colleagues Professor Krish Chatterjee, Dr Carla Moran and Dr David Halsall, he co-directs a national/international referral service for patients with complex disorders of thyroid function, and has authored a number of articles and book chapters providing guidance on how to approach patients with so-called ‘funny’, ‘atypical’ or ‘perplexing’ thyroid function tests. He has a long-standing interest in genetic and acquired disorders of thyroid function, and has assembled a large cohort of patients with thyrotropinomas (TSHomas), who exhibit a rare but important cause of central hyperthyroidism. 

    His current programmes of research include:

    • genetic and acquired disorders of the hypothalamic-pituitary-thyroid axis 

    • molecular endocrine imaging with PET/CT & PET/MR

    • primary medical therapy in acromegaly

    • the endocrine basis of financial decision making

  • Dr Phillip Monaghan

    Phillip trained in the field of Clinical Biochemistry and has been a Clinical Scientist at The Christie Hospital and more recently The Christie Pathology Partnership for the last 8 years. Phillip is an Honorary Lecturer at the University of Manchester and is a member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Test Evaluation. He is a member of the UK NEQAS Steering Committee for Immunochemistry and is Associate Editor for the Annals of Clinical Biochemistry journal. Phillip was awarded the Silver Research Medal from the Royal College of Pathologists in 2012 for his work on serum cortisol measurement in Cushing’s disease; more recently, a Finalist at the Chief Scientific Officer’s Healthcare Science Awards. Phillip is Lead Healthcare Scientist for his Hospital.

  • Dr Dermot Neely

    Consultant in Clinical Biochemistry and Metabolic Medicine and Director of the Newcastle Supra-Regional Assay Services for Hormones and Cardiovascular Biomarkers, Lead Consultant for the Lipid and Metabolic Clinic, Royal Victoria Infirmary and Founder of the Lipid Specialists Advisory Group for the Regional Cardiovascular Network.  An expert adviser on the NICE Lipid Modification Guidelines in 2008 (CG67) and member of the Guideline Development Group for the CG181 guideline in 2012-14.  Standing Member of the NICE Diagnostics Advisory Committee 2014- present.  His research interests are in cardiovascular biomarkers, inherited lipid disorders and clinical trials of novel lipid lowering therapies.

 

Location

To be held at the Royal College of Pathologists, 6 Alie Street, London, E1 8QT